My 3-Step Process for Profiting from the M&A Boom

In my article last week, I predicted that private equity funds would be big buyers of companies in 2020. The next day, I saw this news headline: “Private equity group hunts $1 billion biotech buyout.” Such funds have $1.5 trillion they need to spend — so get ready for hundreds of…

Read More

Tags: M&A Profits

How Iran Could Win a War with the U.S.

As I write this, the markets are shrugging off the tensions brewing in the Middle East... Especially because of Trump’s display of “restraint” after Iran’s attack on Iraqi military outposts. But make no mistake — this conflict is far from over. And while it could put pressure on stock prices globally,…

Read More

Tags: Cyber Security

Beware of Wall Street's Latest "Con" Game

Growing up, my parents taught me that being “direct” was a good thing. Being direct meant being honest, straightforward, forthcoming. So when I heard about startups going public using a new method — something known as a “direct” listing — I was intrigued… Direct listings were promising to give individuals…

Read More

My #1 Strategy to Profit from 2020's Takeover Boom

There’s one key player behind any serious boom in M&A: private equity funds. You see, such firms have just one way to use their pile of money: on acquisitions! So when they’re flush with cash, there’ll be a boom. It’s as simple as that. Well, as it turns out, private…

Read More

Tags: M&A 2020

2020: Your Portfolio on Steroids

During the first half of the 20th century, the sport of powerlifting was dominated by U.S athletes. But at the 1954 powerlifting championships, a new force emerged: the Russians. Which left everyone wondering: How were they able to improve their performance so quickly, and so dramatically? Well, as it turns…

Read More

Tags: 2020

95% of Takeover Deals Have This in Common

As I explained last week, we’re currently in the midst of a rare trend. A wave of consolidation is taking place where big companies are buying smaller ones — i.e., “Mergers & Acquisitions.” Every time this has happened in the past, investors made a fortune. But this time around, you could make a…

Read More

Tags: M&A

Top-Two Biotech Trades That Could Deliver 114% Returns

Biotech is the hottest sector to invest in right now — and the stats prove it: From the number of deals, to the size of the deals, it’s shaping up to be a record-setting year. Even better, acquirers are paying an average premium of 114%. That means, if you scoop…

Read More

Tags: Biotech Profits

Crypto Breakthrough — Unlimited Profits!

Most investors have been struggling to make money in the crypto markets recently. But not us. You see, after a far-reaching investigation — one that took us around the world and lasted months — we discovered an extraordinary strategy for investing in crypto-currencies. And by using this strategy, we’ve been able…

Read More

Tags: Cryptocurrencies Shadow Market

A Key Indicator Just Got Triggered… Use it for 10x Gains

A key market indicator just got triggered. In a report about it last week, Bloomberg wrote that we could be headed for a record. Every time this has happened in the past, investors made a fortune. But this time around, you could make a fortune. In fact, our forecasts show that you could earn…

Read More

Tags: M&A

The Surprising Sector for Overnight Gains of 172%

Whoever said getting rich overnight in the market is impossible doesn’t know about biotech stocks. Yesterday, for example, ArQule (ARQL) surged 104%, and Synthorx (THOR) rallied 172%. This isn’t an anomaly, and it’s not too late to earn similar profits. Hands down, biotech is the hottest sector to invest in…

Read More

Tags: Biotech Public Stocks